<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30228">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02064517</url>
  </required_header>
  <id_info>
    <org_study_id>RB 12.131</org_study_id>
    <secondary_id>Revascularisation pulpaire</secondary_id>
    <nct_id>NCT02064517</nct_id>
  </id_info>
  <brief_title>Treatments of the Post-traumatic Necrosed Immature Teeth</brief_title>
  <official_title>Randomized Comparative Test Multicentrique, Forward-looking Single-blind, Between a Reference Technique and an Innovative Technique.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Estimate if the technique of revascularisation pulpaire (with some hydroxide of calcium)
      allows to obtain a better forecast of preservation of the tooth without complication than
      the conventional technique with the creation of an apicale barrier in the MTA in 24 months.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>Followed in 24 months</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Clinical and radiological follow-up in 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical and radiographic success</measure>
    <time_frame>3-6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Clinical and radiographic success in 3 months, 6 months, 12 months and 18 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return of the pulpaire sensibility</measure>
    <time_frame>3-6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Test of thermal and electric sensibility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obtaining of a closure apicale and of an increase of length and thickness of radiculaires walls</measure>
    <time_frame>3-6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>radiographies with an angulateur and an abutment of repositioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appearance of complications (dyschromie dental)</measure>
    <time_frame>3-6 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Clinical and Radiographic Success in 24 Months</condition>
  <arm_group>
    <arm_group_label>Conventional technique</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>MTA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Revascularisation pulpaire</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hydroxide of calcium</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MTA</intervention_name>
    <description>Creation of a barrier apicale in the MTA</description>
    <arm_group_label>Conventional technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hydroxide of calcium</intervention_name>
    <description>Revascularisation pulpaire with some hydroxide of calcium</description>
    <arm_group_label>Revascularisation pulpaire</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients presenting one or several teeth definitive immature monoradiculées ( open
             apex) with a necrosis post-traumatic pulpaire,

          -  6-year-old patients in 17 years the parents(relatives) of which agree to give a
             lit(enlightened) written consent or patients of more than 18 years old.

        Exclusion Criteria:

          -  general order: any pathology or treatment(processing) dissuading a
             treatment(processing) endodontique (patients at risk of infectious endocarditis) or
             pulling(entailing) an immunosuppression (diabetes, HIV, immunosuppresseurs
             treatments(processings) post-transplant, long-term corticoids, chemotherapies),
             allergy known about the used, antecedent products of cervico-facial radiotherapy,
             presenting subject of the communications problems, the pregnancy and the feeding.

          -  local order: generalized periodontal disease or superior located(localized)
             periodontal pocket in 3mm, crack or fracture(split) radiculaire, radiculaire
             reduction of the necrosed immature tooth
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Reza ARBAB-CHIRANI, PU-PH</last_name>
    <email>reza.arbabchirani@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest - Pôle Organe des Sens</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reza ARBAB-CHIRANI, PU-PH</last_name>
      <email>reza.arbabchirani@chu-brest.fr</email>
    </contact>
    <contact_backup>
      <last_name>Valérie CHEVALIER, MD</last_name>
      <email>valerie.chevalier@chu-brest.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Reza ARBAB-CHIRANI, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie CHEVALIER-HERISSET, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédérique D'ARBONNEAU, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hervé FORAY, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karen VALLEYS, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie ARMENGOL, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabienne PEREZ, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Fabienne PEREZ, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvie DAJEAN-TRUTAUD, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Serena LOPEZ-CAZAUX, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisabeth ROY, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexis GAUDIN, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Louis SIXIOU, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Louis SIXIOU, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexia MARIE-COUSIN, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne DAUTEL, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Justine LE CLERC, AHU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sabrina LEMARECHAL, AU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole MORIN, AHU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthieu PERARD, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yann-Loïg TURPIN, MCU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 14, 2014</lastchanged_date>
  <firstreceived_date>February 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
